Neurology - Page 11
The MD Magazine Neurology - Page 11 specialty page provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.



Latest CME

Latest Headlines

Early Treatment Matters in Multiple Sclerosis
Early treatment benefits MS patients, another study has found.
One of the biggest differences between military and civilian medicine is the very real chance of being deployed to a forward military unit from a stateside appointment. Lessons from those experiences can shape a doctor's practice back in their home country.
The life of a civilian doctor may not be all that different from a military doctor but there are certain differences which can make it a unique experience for those who serve in military medicine.
Calcium supplements may seem to be a safe and effective method to manage osteoporosis, but regular consumption of these pills could increase the risk of dementia in women, specifically those who have experienced cerebrovascular diseases or poor blood flow to the brain, or have suffered a stroke.
Typically, the creation of a new drug is a process of tweaking or combining existing drugs to alter outcomes and side effects. A recent collaboration between researchers from Germany and across the United States, however, takes a novel approach in the battle against opiate addiction: trying to build a new painkiller from scratch.
β€œIn this current investigation, the two most statistically significant findings were that higher HbA2 levels correlated with higher RBC levels and prominently lesser MSSS [multiple sclerosis severity score].”
RNS60, a charge-stabilized nanostructure, shows potential as a beneficial therapy for demyelinating conditions, such as multiple sclerosis (MS), according to the results of a recent study.
Good research has shown that diabetes is linked to heightened risk for brain atrophy, white matter abnormalities, and cognitive impairment. It's a risk factor for dementia, especially if the diabetes is classified as type 2.
Men over the age of 50 who have human immunodeficiency virus (HIV) and who are adherent to an antiretroviral therapy (ART) regimen are at risk for cognitive decline, according to the results of a recent study.

Most Popular in Neurology - Page 11

Recent Published Journal


$vacMongoViewPlus$ $vAR$